To get a sense of who is truly in control of Alcon Inc. ( VTX:ALC ), it is important to understand the ownership structure of ...

Alcon Inc.’s ALC growth is driven by its robust Surgical business. The performance of the Vision Care arm also appears encouraging. However, concerns remain about the macroeconomic headwinds ...

Alcon Inc. (NYSE:ALC), a global leader in eye care products, finds itself at a critical juncture as it navigates a competitive landscape while leveraging its robust product pipeline. The company ...

Alcon (ALC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on September 13. Analyst Larry Biegelsen from Wells Fargo maintained a Buy rating on the ...

David Endicott, Alcon CEO World Sight Day 2024 focuses on the importance of eye care in young people. As the CEO of the ...

Cooper’s pricing power and cost optimization efforts are expected to drive margin expansion. Read why I reiterate a Buy ...

In a report released on October 10, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), ...

PRNewswire Singapore October 8 DKSH Healthcare Business Unit a leading partner for healthcare companies seeking to grow their ...

Even in areas of tech that have done better, bosses note that the war is undermining morale and productivity. What is more, ...

"It's a huge disaster, but what is the fallout?" asks one source after the sequel to the $1 billion hit bombs at the box ...

Faricimab, a humanized, bispecific, immunoglobulin G monoclonal antibody, received FDA approval as an intravitreal injection ...